| Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3 | Thrombosis and Haemostasis |  | | 2020 | 255 | 0 |
|
| Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function | International Journal of Cardiology | | | 2017 | 539 | 0 |
|
| 4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viability | Magnetic Resonance Imaging | | | 2017 | 567 | 2 |
|
| The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation | International journal of cardiology | | | 2016 | 644 | 0 |
|
| Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages | Vascular pharmacology | | | 2016 | 567 | 0 |
|
| Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments | European heart journal | | | 2016 | 639 | 3 |
|
| Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury | Journal of Molecular and Cellular Cardiology | | | 2016 | 593 | 1 |
|
| Prognostic value of PCSK9 levels in patients with acute coronary syndromes | European heart journal | | | 2016 | 633 | 2 |
|
| Protective role of necrostatin-1 in acute myocardial infarction | European journal of clinical investigation | | | 2016 | 512 | 2 |
|
| Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis | Thrombosis and haemostasis | | | 2016 | 733 | 1 |
|
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | | | 2016 | 637 | 6 |
|
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis |  | | 2016 | 774 | 735 |
|
| Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis | Mediators of Inflammation | | | 2016 | 521 | 213 |
|
| Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 | Antioxidants & redox signaling | | | 2015 | 607 | 0 |
|
| Emerging pathophysiological relevance for neutrophils in acute coronary syndromes | European journal of clinical investigation | | | 2015 | 456 | 0 |
|
| The role of adipocytokines in atherogenesis and atheroprogression | Current drug targets | | | 2015 | 552 | 0 |
|
| Leptin/adiponectin ratio predicts post-stroke neurological outcome | European journal of clinical investigation | | | 2015 | 605 | 1 |
|
| Inflammation in arterial diseases | IUBMB life | | | 2015 | 496 | 0 |
|
| Clinical relevance of adverse intracerebral artery remodeling in patients with HIV | Neurology | | | 2015 | 448 | 0 |
|
| Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | European journal of clinical investigation | | | 2015 | 672 | 0 |
|
| Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response | Vascular pharmacology | | | 2015 | 751 | 0 |
|
| Editorial: update on inflammatory targets modulating atherogenesis | Current drug targets | | | 2015 | 512 | 0 |
|
| Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways | Vascular pharmacology | | | 2015 | 855 | 4 |
|
| Update on the role of neutrophils in atherosclerotic plaque vulnerability | Current drug targets | | | 2015 | 516 | 0 |
|
| Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice | Vascular pharmacology | | | 2015 | 611 | 0 |
|
| Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | Thrombosis and haemostasis | | | 2015 | 637 | 5 |
|
| Update on the efficacy of statin treatment in acute coronary syndromes | European journal of clinical investigation | | | 2014 | 605 | 0 |
|
| Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis | European journal of clinical investigation | | | 2014 | 658 | 0 |
|
| Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case | World journal of clinical cases | | | 2014 | 673 | 0 |
|
| Potential pathophysiological role for the vitamin D deficiency in essential hypertension | World journal of cardiology | | | 2014 | 592 | 0 |
|
| Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients | European journal of internal medicine | | | 2014 | 565 | 0 |
|
| Reply to "precipitants of heart failure must be fully considered when predicting readmission" | European journal of clinical investigation | | | 2014 | 618 | 0 |
|
| Inferior vena cava parameters predict re-admission in ischaemic heart failure | European journal of clinical investigation | | | 2014 | 623 | 0 |
|
| Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis | Thrombosis and haemostasis | | | 2014 | 655 | 0 |
|
| Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases | Current medicinal chemistry | | | 2014 | 769 | 0 |
|
| The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome | Thrombosis and haemostasis | | | 2013 | 576 | 0 |
|
| Pathophysiological role of neutrophils in acute myocardial infarction | Thrombosis and haemostasis | | | 2013 | 616 | 0 |
|
| The role of the intraplaque vitamin d system in atherogenesis | Scientífica | | | 2013 | 448 | 374 |
|
| Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases | Thrombosis and haemostasis | | | 2013 | 509 | 0 |
|
| Update on evidence for treatment with ranolazine in stable angina | Schweizerische medizinische Wochenschrift | | | 2013 | 502 | 0 |
|
